TRVN:OTCMKTS
Trevena Inc
0,066Â US$
0,00%
(0,00) 1D
12 tet, 2:57:26 m.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për TRVN...
Kapitalizimi i tregut
57,01 mijë
Vëllimi mesatar
210,00
Vëllimi
9,00
Maksimumi 52-javor
1,50Â US$
Minimumi 52-javor
0,00Â US$
Beta
1,07
Aksionet në qarkullim
864,00 mijë
Numri i punonjësve
23
Kapitalizimi i tregut
57,01 mijë
Vëllimi mesatar
210,00
Vëllimi
9,00
Maksimumi 52-javor
1,50Â US$
Minimumi 52-javor
0,00Â US$
Beta
1,07
Aksionet në qarkullim
864,00 mijë
Numri i punonjësve
23
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Yahoo Finance
·
7 minuta më parë
Stock market today: Dow, S&P 500, Nasdaq futures mixed amid volatile week
The Globe and Mail
·
47 minuta më parë
TNL Mediagene Regains Compliance with Nasdaq Minimum Bid Price Requirement
Seeking Alpha
·
52 minuta më parë
Dow Jones Bullish Catch-Up Over Nasdaq 100 As AI Rotation Accelerates
Investor's Business Daily
·
8 orë më parë
Futures Mixed; Anthropic Value, Tesla Roadster In Focus
Profili
Trevena, Inc. is a clinical stage biopharmaceutical company, headquartered in Chesterbrook, Pennsylvania, USA, and is involved in the discovery and development of G-protein coupled receptors biased ligands. Trevena was founded in 2007 with technology licensed from Duke University, which originated in the labs of company founders Robert Lefkowitz winner of the 2012 Nobel Prize in Chemistry and Howard Rockman. Trevena's approach to drug discovery is based on utilizing ligand bias, or functional selectivity, at GPCR targets to produce drugs with improved efficacy and reduced side effect profiles. Trevena was named one of the top 15 US startups of 2008 by Business Week.
Trevena's expertise lies in engineering "biased ligands" that activate only the beneficial signaling pathways downstream of a GPCR to unlock new biology and avoid drug adverse effects. Trevena's pipeline currently includes a clinical stage mu-opioid biased ligand for post-operative pain, and discovery-stage programs for chronic pain, migraine, and Parkinson's disease. Wikipedia
Rreth Trevena Inc
Drejtori ekzekutiv-
Punonjësit23
Themeluar më2007
SeliaAtlanta, Georgia, Shtetet e Bashkuara të Amerikës
Sektori-
Uebsajtitrevena.com